At this week’s International Solid State Circuits Conference (ISSCC2014), imec and Holst Centre, together with Olympus, demonstrated a low-power single channel implantable electrocardiography (ECG) acquisition chip with analog feature extraction, which enables precise monitoring of the signal activity in a selected frequency band.
Research and Markets has announced the addition of the "Sensors for Home Healthcare Applications: Market & Technology Analysis" report to their offering.
Dexcom, Inc., the leader in continuous glucose monitoring (CGM), announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM device: Dexcom G4® PLATINUM (Pediatric) for use in children ages 2 to 17 years with diabetes. Already approved for adults 18 and older, the Dexcom G4 PLATINUM (Pediatric) is now the only CGM system approved for children as young as two years old.
BioControl Medical, a medical device company headquartered in Yehud, Israel, has received approval from the Israel Ministry of Health to conduct a clinical trial of its CardioFit® system in patients with chronic heart failure (HF) as part of INOVATE-HF.
Animas Canada, a division of LifeScan Canada Ltd., today announced the launch of the Animas® Vibe™ insulin pump and CGM system in Canada, providing a new diabetes management solution for Canadians living with Type 1 diabetes.
A recent study published in MEDSURG Nursing, the official Journal of the Academy of Medical-Surgical Nurses, reported: "Based on the results of this study, temporal artery thermometers appear to be a reliable way to measure temperature noninvasively in hospitalized patients."
Intellirod Spine, the spinal implant company developing implantable wireless sensor technology to aid in the assessment of spine fusion, secured debt financing of $1.6 million from the Ohio Third Frontier's Commercial Acceleration Loan Fund (CALF). This award allows the company to accelerate its plan to commercialize the Intellirod™ Sensor and related lumbar fusion implants.
Integrity Applications, Inc., developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, has entered into a distribution agreement appointing Ultramedix Australasia Pty Ltd., with their depth of specialist clinical expertise and expertise in engineering, sales and marketing in the high-tech medical industry, as the exclusive distributor of the GlucoTrack device in Australia and New Zealand.
Mio Global, makers of the wrist-worn heart rate monitors Mio ALPHA and Mio LINK, together with Adidas, today announced that the heart-rate monitoring technology featured in the miCoach SMART RUN watch which has been selected as a Health and Fitness Honoree in the CES Innovations Design and Engineering Awards, is the Mio Continuous Heart Rate technology.
Polar, the leader in heart rate monitoring and fitness assessment technologies, today unveiled the Polar V800, the smartest and most advanced training computer designed for many different sports and athletic endeavors. The Polar V800 features integrated GPS and 24/7 activity tracking with customizable multisport profiles.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.